Waleed H. Hassanein - 01 Sep 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
01 Sep 2023
Transactions value $
-$511,920
Form type
4
Filing time
06 Sep 2023, 16:31:49 UTC
Previous filing
03 Aug 2023
Next filing
09 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Sale -$4.13K -63 -0.01% $65.63 537K 01 Sep 2023 Direct F1
transaction TMDX Common Stock Sale -$138K -2.05K -0.38% $67.35 535K 01 Sep 2023 Direct F1, F2
transaction TMDX Common Stock Sale -$295K -4.31K -0.81% $68.55 530K 01 Sep 2023 Direct F1, F3
transaction TMDX Common Stock Sale -$74.6K -1.08K -0.2% $68.95 529K 01 Sep 2023 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 14, 2022.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $66.85 to $67.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $67.85 to $68.845, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $68.85 to $69.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.